MCID: MDD003
MIFTS: 36

Middle Cerebral Artery Infarction

Categories: Cardiovascular diseases, Neuronal diseases

Aliases & Classifications for Middle Cerebral Artery Infarction

MalaCards integrated aliases for Middle Cerebral Artery Infarction:

Name: Middle Cerebral Artery Infarction 12 15 37 17
Infarction, Middle Cerebral Artery 43 71
Infarction Middle Cerebral Artery 54

Classifications:



External Ids:

Disease Ontology 12 DOID:3525
MeSH 43 D020244
UMLS 71 C0740392

Summaries for Middle Cerebral Artery Infarction

MalaCards based summary : Middle Cerebral Artery Infarction, also known as infarction, middle cerebral artery, is related to head injury and traumatic brain injury. An important gene associated with Middle Cerebral Artery Infarction is S100B (S100 Calcium Binding Protein B), and among its related pathways/superpathways are Fluid shear stress and atherosclerosis and Neural Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Abciximab and Platelet Aggregation Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and heart.

Related Diseases for Middle Cerebral Artery Infarction

Diseases related to Middle Cerebral Artery Infarction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 185)
# Related Disease Score Top Affiliating Genes
1 head injury 30.9 S100B ENO2
2 traumatic brain injury 30.5 S100B ENO2
3 brain injury 30.5 S100B ENO2
4 hemiplegia 30.3 S100B PLG ENO2 EDN1
5 marantic endocarditis 29.9 PLG PLAT
6 facial paralysis 29.9 PLG CD40LG
7 carotid artery occlusion 29.7 PLG PLAT
8 obstructive hydrocephalus 29.6 PLG PLAT ENO2
9 patent foramen ovale 29.1 PLG PLAT EDN1 CD40LG
10 basilar artery occlusion 29.0 PLG PLAT MRS2
11 ocular motor apraxia 10.7
12 brain edema 10.6
13 hydrops, lactic acidosis, and sideroblastic anemia 10.5
14 aphasia 10.5
15 intracranial cysts 10.5 S100B ENO2
16 bednar tumor 10.5 S100B ENO2
17 meningeal melanocytoma 10.5 S100B ENO2
18 papillary ependymoma 10.4 S100B ENO2
19 pineocytoma 10.4 S100B ENO2
20 intracranial hypertension 10.4
21 post-cardiac arrest syndrome 10.4 S100B ENO2
22 akinetic mutism 10.4 S100B ENO2
23 ossifying fibromyxoid tumor 10.4 S100B ENO2
24 extraosseous ewing sarcoma 10.4 S100B ENO2
25 optic nerve glioma 10.4 S100B ENO2
26 hydrocephalus 10.4
27 subleukemic leukemia 10.4 S100B ENO2
28 cerebrovascular benign neoplasm 10.3 KRT18 ENO2
29 asphyxia neonatorum 10.3 S100B ENO2
30 hypoganglionosis 10.3 S100B NCAM1
31 pineal gland cancer 10.3 KRT18 ENO2
32 microglandular adenosis 10.3 S100B KRT18
33 ureter small cell carcinoma 10.3 NCAM1 ENO2
34 anal neuroendocrine tumor 10.3 NCAM1 ENO2
35 urinary bladder small cell neuroendocrine carcinoma 10.3 NCAM1 ENO2
36 chordoid meningioma 10.3 S100B NCAM1
37 cerebellopontine angle primitive neuroectodermal 10.3 NCAM1 ENO2
38 gastric small cell carcinoma 10.3 NCAM1 ENO2
39 subependymoma 10.3 NCAM1 ENO2
40 cerebral artery occlusion 10.3
41 visual epilepsy 10.3
42 48,xyyy 10.3
43 seizure disorder 10.3
44 cervical large cell neuroendocrine carcinoma 10.3 NCAM1 ENO2
45 miliary tuberculosis 10.3 ENO2 CD40LG
46 cutaneous ganglioneuroma 10.3 NCAM1 ENO2
47 endometrial small cell carcinoma 10.3 NCAM1 ENO2
48 orbital cancer 10.3 NCAM1 ENO2
49 gallbladder small cell carcinoma 10.3 NCAM1 ENO2
50 bladder lateral wall cancer 10.3 NCAM1 ENO2

Graphical network of the top 20 diseases related to Middle Cerebral Artery Infarction:



Diseases related to Middle Cerebral Artery Infarction

Symptoms & Phenotypes for Middle Cerebral Artery Infarction

Drugs & Therapeutics for Middle Cerebral Artery Infarction

Drugs for Middle Cerebral Artery Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Abciximab Approved Phase 4 143653-53-6
2 Platelet Aggregation Inhibitors Phase 4
3 Anticoagulants Phase 4
4
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
5
Clopidogrel Approved Phase 3 120202-66-6, 113665-84-2 60606
6
Mannitol Approved, Investigational Phase 3 69-65-8 453 6251
7 Tissue Plasminogen Activator Phase 3
8 Fibrinolytic Agents Phase 3
9 Anti-Inflammatory Agents Phase 3
10 Neurotransmitter Agents Phase 3
11 Antipyretics Phase 3
12 Anti-Inflammatory Agents, Non-Steroidal Phase 3
13 Analgesics, Non-Narcotic Phase 3
14 Cyclooxygenase Inhibitors Phase 3
15 Antirheumatic Agents Phase 3
16 Purinergic P2Y Receptor Antagonists Phase 3
17 Analgesics Phase 3
18 Hematinics Phase 2, Phase 3
19 Epoetin alfa Phase 2, Phase 3 113427-24-0
20
Iron Approved, Experimental Phase 2 7439-89-6, 15438-31-0 23925 27284
21
Deferoxamine Approved, Investigational Phase 2 70-51-9 2973
22 Siderophores Phase 2
23 Iron Chelating Agents Phase 2
24 Chelating Agents Phase 2
25
Lidocaine Approved, Vet_approved 137-58-6 3676
26
Glycerol Approved, Investigational 56-81-5 753
27
Ginseng Approved, Investigational, Nutraceutical 50647-08-0
28 Anesthetics
29 Hydroxymethylglutaryl-CoA Reductase Inhibitors

Interventional clinical trials:

(show all 41)
# Name Status NCT ID Phase Drugs
1 Thrombectomy Under Reopro Versus Alteplase and Neurologic Deficit Outcome Trial Terminated NCT02016547 Phase 4 alteplase 0.9mg/kg (10% by IV bolus following by 90% by 1 hour IV drip)
2 Randomized, Double Blind, Placebo Controlled, Two Parallel Group Study to Evaluate the Efficacy and Safety of Piracetam, 12 g Intravenous (IV) Infusion Within 7 Hour (h) Post Stroke Onset, Followed by 12 g/d for 4 Weeks (IV Ampoules, Oral Solution) and 4.8 g/d for 8 Weeks (Tablets) in Adult Subjects With an Acute Ischemic Middle Cerebral Artery Stroke Terminated NCT01883011 Phase 4 Piracetam
3 Transcranial Ultrasound Enhanced Thrombolysis (TRUST) Unknown status NCT00336596 Phase 3
4 The Carotid and Middle Cerebral Artery Occlusion Surgery Study Unknown status NCT01758614 Phase 3 Aspirin;Clopidogrel
5 German Multicenter EPO Stroke Trial (Phase II/III) Completed NCT00604630 Phase 2, Phase 3 recombinant human erythropoietin alfa;0.9% NaCl
6 Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts : A Sequential Design, Multicenter, Randomized, Controlled Trial Terminated NCT00190203 Phase 3
7 Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial Terminated NCT02002234 Phase 3
8 An Open Lable, Phase II Exploratory Study Assessing the Efficacy of Intravenous Autologous Mesenchymal Stem Cells in Patients With Middle Cerebral Artery Infarct Unknown status NCT01461720 Phase 2
9 Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Patients With Ischemic Stroke: a Randomized Controlled Trial Unknown status NCT01468064 Phase 1, Phase 2
10 A Phase I/II Safety and Tolerability Study Following the Autologous Infusion of Immuno-selected CD34+ Subset Bone Marrow Stem Cells Into Patients With Acute Total Anterior Circulation Ischaemic Stroke Completed NCT00535197 Phase 1, Phase 2
11 Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment Completed NCT00761982 Phase 1, Phase 2
12 Phase II Study of Autologous Peripheral Blood CD34 Stem Cell Implantation in Chronic Stroke Patients Completed NCT00950521 Phase 2 convention therapy
13 Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke: A Multi-Institutional Project Completed NCT02425670 Phase 2
14 Double-blind, Randomized, Placebo Controlled, Dose-finding Phase 2 Clinical Trial of Intravenous Deferoxamine in Patients With Acute Ischemic Stroke Treated With Tissue Plasminogen Activator Completed NCT00777140 Phase 2 Deferoxamine
15 Effect of Different Transplantation Time for Human Umbilical Cord Mesenchymal Stem Cells(MSCs) on Prognosis of Acute Cerebral Infarction Patients Recruiting NCT04093336 Phase 1, Phase 2
16 A Phase 2A, Prospective, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults Following Ischemic Stroke Terminated NCT01310114 Phase 2 Placebo
17 A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of MK0724 Intravenous Infusion on the Amelioration of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke Terminated NCT00401310 Phase 2 Comparator: Placebo;Comparator: MK0724
18 Randomized Therapeutic Study Assessing the Superiority of a Sequential Intravenous Thrombolysis Treatment (Rt-PA + Tenecteplase) in Comparison With Rt-PA Standard Treatment in Proximal Middle Cerebral Artery Occlusion (DIVA). Withdrawn NCT02338466 Phase 2 rt-PA;tenecteplase
19 Evaluation of Safety, Feasibility and Treatment Potential for Old Stroke Patients Using Intracerebral Implantation of Olfactory Ensheathing Cells Unknown status NCT01327768 Phase 1
20 An Exploratory Clinical Trial to Assess Treatment of Chronic Ischemic Stroke With Brain Transplants of Purified CD34+ Umbilical Cord Blood Stem Cells Unknown status NCT01438593 Phase 1
21 Phase I Study of Autologous Bone Marrow Cell Transplantation in Patient With Ischemic Stroke Completed NCT00473057 Phase 1
22 To Evaluate the Safety, Feasibility and Clinical Outcome of Intraarterial Infusion of Bone Marrow Derived Mononuclear Cells in Subacute Ischaemic Stroke Patients Completed NCT03080571 Phase 1
23 To Observe Delayed Neuronal Death of Hippocampus After Middle Cerebral Artery Infarction Through Magnetic Resonance Imaging(MRI) Volume Measurement and Magnetic Resonance Spectroscopy(MRS) Study of Hippocampus Unknown status NCT00867581
24 Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage Unknown status NCT01537263
25 Trial of Prophylactic Decompressive Craniectomy for Poor-grade Aneurysmal Subarachnoid Hemorrhage Unknown status NCT02995928
26 The Lokomat Gait Orthosis Compared to Categorized Gait Training by Physical Therapists in Patients Early Post Stroke Completed NCT00612300 Early Phase 1
27 A Randomized Controlled Study Comparing 2 Surgical Techniques for Decompressive Craniectomy: With Watertight Duraplasty Versus Without Watertight Duraplasty. Completed NCT02594137
28 Modulating Interaction of Motor Learning Networks in Rehabilitation of Stroke Completed NCT03086551
29 Osmotic Agents Will Improve the Midline Shift in Middle Cerebral Artery Stroke Larger Than 70 cc by 1 mm Completed NCT04156490
30 Intracranial Pressure After Decompressive Craniectomy Completed NCT03364634
31 Dual-Task Training With Variable Priority Instructional Sets Improve the Gait Parameters in Patients With Chronic Stroke Completed NCT03752788
32 The Impact of Cranioplasty on Local and Global Cerebral Blood Flow as Clinical Outcome Prognostic Factor in Patients Undergoing Decompressive Craniectomy for Severe Head Injury. Completed NCT01113645
33 The Brain Heart Interaction in Acute Stroke Completed NCT02734082
34 A Non-interventional, Controlled, Open-label, Observational Registry Study to Investigate the Safety and Effectiveness of LUOTAI (Panax Notoginseng) Injectable and Soft Capsules in Patients With Acute Ischemic Stroke in Vietnam Recruiting NCT03679364
35 Vacuum Drains vs Passive Drains vs no Drains in Decompressive Craniectomies - A Randomized Controlled Trial on Subgaleal Drain Complication Rates Recruiting NCT03777774
36 The Manifestation of Surface EMG of Swallowing Muscles in Stroke Patients With Respiratory Muscle Training. A Prospective Study. Recruiting NCT03767998
37 Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Decompressive Craniectomy Not yet recruiting NCT03221959
38 Pilot Study Using Targeted High Definition Transcranial Direct Current Stimulation to Promote Upper Extremity Motor Function in Patients With Subacute Middle Cerebral Artery (MCA) Stroke Not yet recruiting NCT04000269
39 Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Decompressive Craniectomy Not yet recruiting NCT03641963
40 A Prospective International Multicentre Randomised Controlled Single Blind Clinical Investigation of Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Suspended NCT03098732
41 Stereotactic Infarct Tissue Aspiration (SITA) for Malignant Infarction of Middle Cerebral Artery Terminated NCT02609256

Search NIH Clinical Center for Middle Cerebral Artery Infarction

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Middle Cerebral Artery Infarction cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Middle Cerebral Artery Infarction:
Neuroncell, bone marrow-derived mesenchymal stem cells for middle cerebral artery infarct
Embryonic/Adult Cultured Cells Related to Middle Cerebral Artery Infarction:
Bone marrow-derived mesenchymal stem cells (family)

Cochrane evidence based reviews: infarction, middle cerebral artery

Genetic Tests for Middle Cerebral Artery Infarction

Anatomical Context for Middle Cerebral Artery Infarction

MalaCards organs/tissues related to Middle Cerebral Artery Infarction:

40
Brain, Bone, Heart, Bone Marrow, Pituitary, Cortex, Breast

Publications for Middle Cerebral Artery Infarction

Articles related to Middle Cerebral Artery Infarction:

(show top 50) (show all 473)
# Title Authors PMID Year
1
Association between preoperative midline shift growing rate and outcomes of decompressive craniectomy in patients with malignant middle cerebral artery infarction. 61
32031070 2020
2
Decompressive hemicraniectomy versus medical treatment of malignant middle cerebral artery infarction: a systematic review and meta-analysis. 61
31854446 2020
3
Outcomes of therapeutic hypothermia in patients treated with decompressive craniectomy for malignant Middle cerebral artery infarction: A systematic review and meta-analysis. 61
31710882 2020
4
Early and Sustained Increases in Leukotriene B4 Levels Are Associated with Poor Clinical Outcome in Ischemic Stroke Patients. 61
31520306 2020
5
Application of Magnetic Resonance Imaging Molecular Probe in the Study of Pluripotent Stem Cell-derived Neural Stem Cells for the Treatment of Post-traumatic Paralysis of Cerebral Infarction. 61
32001413 2020
6
High serum substance P levels and mortality after malignant middle cerebral artery infarction. 61
31991332 2020
7
Outcome After Decompressive Craniectomy for Middle Cerebral Artery Infarction: Timing of the Intervention. 61
31943069 2020
8
Decompressive craniectomy in malignant middle cerebral artery infarction: family perception, outcome and prognostic factors. 61
31445797 2020
9
High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality. 61
31442656 2019
10
Serum Caspase-3 Levels and Early Mortality of Patients with Malignant Middle Cerebral Artery Infarction. 61
31115825 2019
11
Pathological Yawning in Patients with Acute Middle Cerebral Artery Infarction: Prognostic Significance and Association with the Infarct Location 61
31594283 2019
12
Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients. 61
31795260 2019
13
Cortical Spreading Depression Phenomena Are Frequent in Ischemic and Traumatic Penumbra: A Prospective Study in Patients With Traumatic Brain Injury and Large Hemispheric Ischemic Stroke. 61
31702708 2019
14
Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels. 61
31623565 2019
15
Letter by Wu et al Regarding Article, "Intracranial Cerebrospinal Fluid Volume as a Predictor of Malignant Middle Cerebral Artery Infarction". 61
31451101 2019
16
Response by Kauw et al to Letter Regarding Article, "Intracranial Cerebrospinal Fluid Volume as a Predictor of Malignant Middle Cerebral Artery Infarction". 61
31451100 2019
17
DNA and RNA oxidative damage are associated to mortality in patients with cerebral infarction. 61
31492477 2019
18
Novel Hemicraniectomy Technique for Malignant Middle Cerebral Artery Infarction: Technical Note. 61
30649476 2019
19
Commentary: Novel Hemicraniectomy Technique for Malignant Middle Cerebral Artery Infarction: Technical Note. 61
30888425 2019
20
Suprasellar ganglioglioma presenting as a middle cerebral artery infarction. 61
31289852 2019
21
High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients. 61
31319804 2019
22
Targeted temperature management in severe middle cerebral artery infarction-related out-of-hospital cardiac arrest. 61
30876790 2019
23
Corrigendum to "Impact of timing of cranioplasty on hydrocephalus after decompressive hemicraniectomy in malignant middle cerebral artery infarction" [Clin. Neurol. Neurosurg. (2017) 27-34]. 61
31054783 2019
24
Letter to the Editor Regarding "Decompressive Craniotomy for Malignant Middle Cerebral Artery Infarction: Optimal Timing and Literature Review". 61
31429408 2019
25
Mirror therapy and treadmill training for a patient with chronic stroke: A case report. 61
29589777 2019
26
Intracranial Cerebrospinal Fluid Volume as a Predictor of Malignant Middle Cerebral Artery Infarction. 61
31092157 2019
27
Status epilepticus and bilateral middle cerebral artery infarction: A rare presentation after viper bite. 61
31070155 2019
28
The development and evolution of "cerebral thermometry": Clinical applications of a nineteenth-century approach to cerebral localization and neurological diagnosis. 61
31136252 2019
29
Obsessive-Compulsive Disorder Following Cerebrovascular Accident: A Case Report and Literature Review. 61
30638936 2019
30
Association Between Duration of Dysphagia Recovery and Lesion Location on Magnetic Resonance Imaging in Patients With Middle Cerebral Artery Infarction. 61
31072080 2019
31
Clinical efficacy of collateral circulation in the evaluation of endovascular treatment for acute internal carotid artery occlusion. 61
31008404 2019
32
Decompressive Hemicraniectomy in the Treatment of Malignant Middle Cerebral Artery Infarction: A Meta-Analysis. 61
30500591 2019
33
Malignant Middle Cerebral Artery Infarction Due to Hyponatremia Following Traumatic Brain Injury: A Case Report. 61
30808857 2019
34
A cost-utility analysis of decompressive hemicraniectomy versus medical treatment in the management of space-occupying brain oedema post middle cerebral artery infarction. 61
30266037 2019
35
Selective Brain Hypothermia Augmenting Neuroprotective Effects of Decompressive Craniectomy for Permanent Middle Cerebral Artery Infarction in a Rat Model. 61
30261392 2019
36
Timing of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction: A Single-Center Analysis. 61
30704138 2019
37
Early signs of middle cerebral artery infarction on multidetector computed tomography: Review of 20 cases. 61
31001598 2019
38
Strokectomy and Extensive Cisternal CSF Drain for Acute Management of Malignant Middle Cerebral Artery Infarction: Technical Note and Case Series. 61
31616366 2019
39
Decompressive Cranioplasty (Osteoplastic Hinged Craniectomy): A Novel Technique for Increased Intracranial Pressure-Initial Experience and Outcome. 61
30610974 2019
40
NIHSS sub-item scores predict collateral flow in acute middle cerebral artery infarction. 61
29991309 2018
41
A Systematic Review and Meta-Analysis of the Effectiveness of Surgical Decompression in Treating Patients with Malignant Middle Cerebral Artery Infarction. 61
30193963 2018
42
Stereotactic Aspiration of Necrotic Brain Tissue for Treating Malignant Middle Cerebral Artery Infarction: A Report of 13 Consecutive Cases. 61
30404052 2018
43
MiR-940 regulates angiogenesis after cerebral infarction through VEGF. 61
30536336 2018
44
Decompressive hemicraniectomy after malignant middle cerebral artery infarction: does hospital of origin matter? 61
30288900 2018
45
Spinal canal meningioma mimicking posterior fossa ischemia on CT perfusion: A CT perfusion pitfall. 61
30228845 2018
46
Stroke due to Paradoxical Embolization Related to Fibroid Uterus Enlargement Compressing the Right Common Iliac Vein. 61
30627098 2018
47
Hemicraniectomy for Malignant Middle Cerebral Artery Syndrome: A Review of Functional Outcomes in Two High-Volume Stroke Centers. 61
29776804 2018
48
Serum melatonin levels are associated with mortality in patients with malignant middle cerebral artery infarction. 61
29848129 2018
49
Decompressive Craniotomy for Malignant Middle Cerebral Artery Infarction: Optimal Timing and Literature Review. 61
29653270 2018
50
Successful hemispherotomy in two refractory epilepsy patients with cerebral hemiatrophy and contralateral EEG abnormalities. 61
29550191 2018

Variations for Middle Cerebral Artery Infarction

Expression for Middle Cerebral Artery Infarction

Search GEO for disease gene expression data for Middle Cerebral Artery Infarction.

Pathways for Middle Cerebral Artery Infarction

Pathways related to Middle Cerebral Artery Infarction according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.58 PLAT PDGFA EDN1
2 11.03 S100B PDGFA NCAM1
3 10.68 PLG PLAT
4 10.39 PLG NCAM1 LYVE1
5 10.27 PLG PLAT

GO Terms for Middle Cerebral Artery Infarction

Cellular components related to Middle Cerebral Artery Infarction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.56 S100B PLG PLAT PDGFA NCAM1 IL27
2 cell surface GO:0009986 9.55 PLG PLAT PDGFA NCAM1 CD40LG
3 extracellular space GO:0005615 9.23 S100B PLG PLAT PDGFA IL27 ENO2

Biological processes related to Middle Cerebral Artery Infarction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 platelet-derived growth factor receptor signaling pathway GO:0048008 9.16 PLAT PDGFA
2 fibrinolysis GO:0042730 8.96 PLG PLAT
3 trans-synaptic signaling by BDNF, modulating synaptic transmission GO:0099183 8.62 PLG PLAT

Molecular functions related to Middle Cerebral Artery Infarction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor binding GO:0005102 9.02 S100B PLG PLAT IL27 EDN1

Sources for Middle Cerebral Artery Infarction

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....